Skip to main content

Clinical trial AURA

Avelumab as neoadjuvant therapy in subjects with urothelial muscle invasive bladder cancers

Cancers
Organ Ureters - bladder - urethra
Trial status Trial open for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor Institut Jules Bordet
EudraCT Identifier 2017-002758-35
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03674424
Inclusion criteria Non metastatic urothelial carcinoma candidate for surgeryCisplatin eligible and ineligible
Last update